Antiphospholipid Syndrome  >>  rivaroxaban  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
rivaroxaban / Generic mfg.
RAPS, NCT02116036: Rivaroxaban for Antiphospholipid Antibody Syndrome

Completed
4
81
Canada
Rivaroxaban, Xarelto
St. Joseph's Healthcare Hamilton, Heart and Stroke Foundation of Canada, Bayer, Hamilton Health Sciences Corporation, Jewish General Hospital, University of Alberta, The Ottawa Hospital, Queen Elizabeth II Health Sciences Centre
Antiphospholipid Antibody Syndrome
09/17
09/17

Download Options